Trials / Terminated
TerminatedNCT01556828
Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to identify genetic changes associated with the initiation, progression, and treatment response of response of cutaneous and hematologic disorders using recently developed high-throughput sequencing technologies. The improved understanding of the genetic changes associated with cutaneous and hematologic disorders may lead to improved diagnostic, prognostic and therapeutic options for these disorders.
Conditions
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2012-03-16
- Last updated
- 2016-06-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01556828. Inclusion in this directory is not an endorsement.